Research progress on influencing factors of immunotherapy-related adverse events in patients with malignant tumors

VernacularTitle:恶性肿瘤患者免疫治疗相关不良反应影响因素的研究进展
Author: Yajie SI ¹ ; Renshan CUI ; Yue XIN ; Wenwen HU
Author Information

1. 辽宁中医药大学护理学院,辽宁沈阳 110847
Keywords: malignant tumor; immune checkpoint inhibitors; immune-related adverse events; influencing factors
From: Journal of Shenyang Medical College 2024;26(5):524-528
CountryChina
Language:Chinese
Abstract: Immune checkpoint inhibitors(ICIs)are an emerging tumor treatment approach following traditional surgery,chemoradiotherapy and targeted therapy.They have proven to be effective in a variety of cancers.However,they may induce immune-related adverse events(irAEs)during treatment,which may affect patients'quality of life and lead to treatment interruption or cessation.The key to preventing irAEs is early evaluation and identification of medical staff.Therefore,this article reviews the clinical manifestations and influencing factors of irAEs to help the early identification of high-risk groups and provide reference for clinical nursing work.